A carregar...

Multivalent peptoid conjugates which overcome enzalutamide resistance in prostate cancer cells

Development of resistance to anti-androgens for treating advanced prostate cancer is a growing concern, and extends to recently developed therapeutics, including enzalutamide. Therefore, new strategies to block androgen receptor (AR) function in prostate cancer are required. Here we report the chara...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Wang, Yu, Dehigaspitiya, Dilani C., Levine, Paul M., Profit, Adam A., Haugbro, Michael, Imberg-Kazdan, Keren, Logan, Susan K., Kirshenbaum, Kent, Garabedian, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5010535/
https://ncbi.nlm.nih.gov/pubmed/27488525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-0385
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!